期刊文献+

他汀类药物对脑梗死患者血浆同型半胱氨酸的影响 被引量:5

下载PDF
导出
摘要 目的探究他汀类药物对脑梗死患者血浆同型半胱氨酸变化的影响。方法 2011-04—2012-010收治以各种神经功能受损为病症的患者138例,经头颅MR及CT影像学检查证实为脑梗死。随机分为治疗组72例和对照组66例。对照组采用脑梗死患者常规疗法,治疗组在常规疗法基础上加用阿托伐他汀治疗,2组均治疗6周。2组患者治疗前后均测定血浆Hcy浓度。比较其前后血浆Hcy水平及治疗效果。结果 6周后治疗组患者血浆Hcy低于对照组;治疗组疗效好于对照组。结论以阿托伐他汀为代表的他汀类药物可以降低脑梗死患者的血浆Hcy水平,提高脑梗死患者的治疗效果。
出处 《中国实用神经疾病杂志》 2013年第7期38-39,共2页 Chinese Journal of Practical Nervous Diseases
  • 相关文献

参考文献7

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33022
  • 2Sacco RL,Roberts JK,Jaxobs BS. Homocysteine as a risk fac- tor for ischemic stroke: an epidemiological story in evolution [J]. Neuroepidemiology, 1998,17(4) : 167-173.
  • 3Paddar R, Sivasubramanian N, Dibello PM, et al. Homocyste- ine induces expression and secretion of monocyte chemoattrac rant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease [J]. Circulation, 2001, 103(22) :2 717-2 723.
  • 4Auyeunq KK,Woo CW, Sung F L, et al. Hyper-homocys teine- mia activates nuclear factor-KB in endothelial cells vis oxidative strees[J]. Circulation Res, 2004,94 (1) : 28-36.
  • 5Clifton DR,Rydkins E, Huyck H,et al. Express and secretion of chemotactic cytokines IL-8 and MCP-1 by human endothelial cells aner rickettsia riekettsii infection: regulation by nuclear tranecription factor NF kappa B [-J . Int J Med Mierobiod, 2005,295(4) :267 278.
  • 6耿德勤,杨巧云,李智勇,阎蕾,李继珍,曹金霞,樊红彬,董瑞国.通心络胶囊对急性脑梗死患者血清同型半胱氨酸含量的影响[J].中国临床实用医学,2007,1(3). 被引量:7
  • 7顾力华,姜丽芸,任亢宗.阿托伐他汀对急性脑梗死患者血清高敏C反应蛋白及血脂的影响[J].中国医药导刊,2009,11(5):792-793. 被引量:2

二级参考文献21

  • 1王爱民,周颖,肖波,张智博.脑梗死患者血清高敏C反应蛋白水平的变化及其临床意义[J].临床神经病学杂志,2005,18(2):153-154. 被引量:132
  • 2Di Napoli M,Schwaninger M,Cappelli R,et al.Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke:a statement for health care professionals from the CRP pooling project members[J].Stroke,25,36:1316-1329.
  • 3BulmanN,Lev Y,LeibaR,eta.l IncreasedC-reactive protein levels in the polycystic orary syndrome:amarker of cardiovascular disease[J].J Clin Endocrinol Metab,2004 ; 89:2160.
  • 4Amareneo P,Bogouaslavsky J,Callahan A,et al.High-dose ator-vastatin after stroke or transient ischemic attack[J].N Engl J Med,2006 ; 355:549-559.
  • 5Amarenco P,Lavallee P,Touboul PJ.Stroke prevention,blood cholesterol,and statins[J].Lancet,2004 ;3:271-278.
  • 6Collins R,Annitage J,Parish S,et al.Effects of cholesterol-low-ering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions[J].Lancet,2004 ;363:757-767.
  • 7Graham IM;Daly LE;Refssum HM.Plasma homocysteine as a risk factor for vascular disease.The European Concerted Action Project,1997.
  • 8Harpel PC;Zhang XX;Borth W.Homocysteine and hemostasis:pathogenic mechanisms predisposing to thrombosis[J]Journal of Nutrition,1996(4 suppl):1285s-1289s.
  • 9Reis RP,Azinheira J,Reis HP. Homocysteinemia as a risk factor in early cerebrovascular disease[J].Acta Medica Portuguesa,1994,(05):285-289.
  • 10Motulsky AG. Nutritional ecogenetics:homocysteine-related arteriosclerotic vascular disease,neural tube defects,and folic acid[J].American Journal of Human Genetics,1996,(01):17-20.

共引文献33023

同被引文献57

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部